Analyst Ratings for Nuvectis Pharma (NVCT)
NVCT Rating Summary
NVCT Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$39.50 (+71.3%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$39.50 (+71.3%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/1/2026 | Lucid Capital Markets | Elemer Piros | New Coverage | Buy (N/A) |
40.00 (N/A) |
22.73 (23.06) |
1.45% | Details |
| 8/24/2026 | Cantor Fitzgerald | Pete Stavropoulos | New Coverage | Overweight (N/A) |
N/A (N/A) |
23.56 (23.06) |
-2.12% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
